Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
MedImmune enters into strategic cancer vaccine collaboration and license agreement with Inovio Pharmaceuticals
-
AstraZeneca and Heptares Therapeutics enter agreement to develop novel immuno-oncology treatments
-
MedImmune and Mirati Therapeutics partner on immuno-oncology combination in lung cancer
-
AstraZeneca and Isis Pharmaceuticals to discover and develop antisense drugs for cardiovascular, metabolic and renal diseases
-
AstraZeneca PLC H1 2015 results
-
AstraZeneca further sharpens focus through agreement with Genzyme for rare disease medicine Caprelsa
-
AstraZeneca provides update on selumetinib in uveal melanoma
-
AstraZeneca completes agreement with Tillotts Pharma for Entocort
-
AstraZeneca enters option agreement with Kyowa Hakko Kirin for commercialisation of benralizumab in Japan
-
IRESSA approved by US FDA for first-line treatment of patients with advanced EGFR mutation-positive non-small cell lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
